Literature DB >> 25070627

Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays.

Ramakrishna Nirogi1, Raghava Choudary Palacharla, Venkatesham Uthukam, Arunkumar Manoharan, Surya Rao Srikakolapu, Ilayaraja Kalaikadhiban, Rajesh Kumar Boggavarapu, Ranjith Kumar Ponnamaneni, Devender Reddy Ajjala, Gopinadh Bhyrapuneni.   

Abstract

1. Chemical inhibition is the widely used method in reaction phenotyping assays for estimation of specific enzyme contribution to a given metabolic pathway. The results from phenotyping assays depend on the selectivity of chemical inhibitor and the concentration of inhibitor used in the incubation. 2. The higher protein concentrations used in the in vitro phenotyping assays will impact the inhibitory potency of chemical inhibitors. The objective of the study is to evaluate comprehensively the selectivity of chemical inhibitors and to guide in selecting appropriate concentration of the chemical inhibitors to be used in the phenotyping assays based on unbound fractions. 3. Selectivity of chemical inhibitors against nine major CYP450 isoforms was determined in liver microsomes using standard probe substrates. The unbound fractions of the selective inhibitors were determined in human liver microsomes using high-throughput equilibrium dialysis. Combining unbound inhibitor concentrations that are required to inhibit the CYP450 activities by 90% and unbound fractions of the chemical inhibitors in liver microsomes appropriate total concentrations of the inhibitors to be used in the phenotyping assays were reported. 4. The findings suggest that non-specific binding of the chemical inhibitors need to be taken into account while selecting concentrations for phenotyping assays.

Entities:  

Keywords:  Chemical inhibitors; cytochrome P450; reaction phenotyping; unbound fractions

Mesh:

Substances:

Year:  2014        PMID: 25070627     DOI: 10.3109/00498254.2014.945196

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  6 in total

1.  CYP2C19 and 3A4 Dominate Metabolic Clearance and Bioactivation of Terbinafine Based on Computational and Experimental Approaches.

Authors:  Mary A Davis; Dustyn A Barnette; Noah R Flynn; Anirudh S Pidugu; S Joshua Swamidass; Gunnar Boysen; Grover P Miller
Journal:  Chem Res Toxicol       Date:  2019-04-10       Impact factor: 3.739

Review 2.  The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation.

Authors:  Li Di; Amanda Balesano; Samantha Jordan; Sophia M Shi
Journal:  AAPS J       Date:  2021-01-07       Impact factor: 4.009

3.  CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.

Authors:  Mary Alexandra Schleiff; Samantha Crosby; Madison Blue; Benjamin Mark Schleiff; Gunnar Boysen; Grover Paul Miller
Journal:  Biochem Pharmacol       Date:  2021-11-05       Impact factor: 5.858

4.  Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam.

Authors:  Dustyn A Barnette; Mary A Schleiff; Arghya Datta; Noah Flynn; S Joshua Swamidass; Grover P Miller
Journal:  Toxicol Lett       Date:  2020-11-27       Impact factor: 4.372

5.  Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135).

Authors:  Sabrina Jones; Azure L Yarbrough; William E Fantegrossi; Paul L Prather; John M Bush; Anna Radominska-Pandya; Ryoichi Fujiwara
Journal:  Pharmacol Res Perspect       Date:  2020-02

6.  Evaluation of the effects of four types of tea on the activity of cytochrome P450 enzymes with a probe cocktail and HPLC-MS/MS.

Authors:  Xueyan Wang; Yanping Liu; Liming Ye; Ying Wei; Yingqiang Fu; Yu Chen; Linchuan Liao
Journal:  Ann Transl Med       Date:  2022-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.